glp-1 drug news Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 Antagonists Increase Plan Drug
Description
Allulose &
Furthermore, these agents modulate inflammation, reduce apoptosis, and improve stem cell functions even under diabetic or inflammatory conditions
The responsible message: Substantial weight loss usually includes some loss of lean tissue
Novo Nordisk and Ascendis Pharma have partnered to develop a long-acting, monthly GLP-1 drug
What you need to know is covered in this article and infographic
